Results 51 to 60 of about 152,878 (197)

Alternatives to Subcutaneous Immunotherapy for Allergic Rhinitis

Allergies, 2022
Allergic rhinitis (AR) is an important public health issue worldwide due to its increasing prevalence and impact on quality of life, school performance, and work productivity.
Tetsuya Terada, Ryo Kawata
doaj   +1 more source

Subcutaneous Allergen Immunotherapy With Thermosensitive Hydrogel and Recombinant Birch Pollen Allergen Variant, a Randomised Controlled Trial

Clinical &Experimental Allergy, EarlyView.
A Phase 1, randomised, placebo‐controlled, dose‐escalation trial was performed with 30 birch pollen allergic subjects treated with DM‐101PX, that contains a recombinant hypoallergenic variant of Bet v 1 formulated with poloxamer 338 thermosensitive hydrogel.
Anna Nilson, Patricia Couroux, Jaana Haka, Silja Halme, Pekka Mattila, R. J. Joost van Neerven, Rolien Pels‐Rijcken, Janneke Ruinemans‐Koerts, Yvonne Schmidt‐Hieltjes, Anne Marie Salapatek, Kati Sallinen, Kristiina Takkinen, Daphne Tsitoura, Dirk‐Jan Opstelten, Juha Rouvinen   +14 more
wiley   +1 more source

Requirements for acquiring a high-quality house dust mite extract for allergen immunotherapy

Drug Design, Development and Therapy, 2012
Franco Frati,1 Cristoforo Incorvaia,2 Marie David,3 Silvia Scurati,3 Simona Seta,4 Guglielmo Padua,4 Eleonora Cattaneo,1 Carlo Cavaliere,5 Alessia Di Rienzo,6 Ilaria Dell'Albani,1 Paola Puccinelli11Medical and Scientific and Regulatory Department,
Frati F, Incorvaia C, David M, Scurati S, Seta S, Padua G, Cattaneo E, Cavaliere C, Di Rienzo A, Dell'Albani I, Puccinelli P   +10 more
doaj  

Enhanced Efficacy of Sublingual Immunotherapy in Childhood Allergic Asthma by Probiotics

Folia Medica Indonesiana, 2018
It is expected that probiotics may act synergistically to improve the clinical efficacy of sublingual immunotherapy (SLIT). The aim of this study was to investigate the role of probiotics in enhancing efficacy of sublingual immunotherapy in childhood ...
Anang Endaryanto, Mira Irmawati
doaj   +1 more source

Taste aversion and adverse events contribute equally to OIT discontinuation in children: A real‐world multi‐allergen analysis

Pediatric Allergy and Immunology, Volume 37, Issue 9, September 2026.
Overview of discontinuation in a prospective real‐world pediatric OIT cohort, illustrating overall discontinuation, timing and dose at treatment cessation, clinical patterns associated with different reasons for discontinuation, and variation in discontinuation rates across individual food allergens. Abstract Background Although oral immunotherapy (OIT)
Breiding Maria, Höfer Veronika, Boucq Camille, Trück Johannes   +3 more
wiley   +1 more source

Lung-derived innate cytokines: new epigenetic targets of allergen-specific sublingual immunotherapy [PDF]

Iranian Journal of Basic Medical Sciences, 2016
Objective(s):Sublingual allergen-specific immunotherapy is a safe and effective method for treatment of IgE-mediated respiratory allergies; however, the underlying mechanisms are not fully understood.
Abbas Pishdadian, Abdolreza Varasteh, Mehran Gholamin, Leila Roozbeh Nasiraie, Mitra Hosseinpour, Malihe Moghadam, Mojtaba Sankian   +6 more
doaj  

Allergen-specific immunotherapy for allergic asthma: What’s new? [PDF]

Exploration of Asthma & Allergy
Allergen-specific immunotherapy for inhalant allergies, using allergen extracts of proven value, is highly effective in selected patients with allergic rhinoconjunctivitis and allergic asthma.
Chiara Asperti, Martin Penagos, Stephen R. Durham   +2 more
doaj   +1 more source

Immunological mechanisms of sublingual immunotherapy [PDF]

Allergy, 2006
Administration of allergen‐specific immunotherapy by the oral route, sublingual immunotherapy (SLIT), has been shown to be effective, with an improved safety profile compared with subcutaneous administration. However, the precise mechanisms underlying the induction of immune tolerance by SLIT remain unclear.
Akdis CA, Barlan IB, Bahceciler N, Akdis M   +3 more
openaire   +3 more sources

ARIA‐EAACI 2025: Person‐Centred, Digitally Enabled and Artificial Intelligence‐Assisted Change Management in Airway Diseases

Clinical and Translational Allergy, Volume 16, Issue 8, August 2026.
ABSTRACT Allergic Rhinitis and its Impact on Asthma (ARIA) was, up until 2017, a guideline using the best evidence (Grading of Recommendations, Assessment, Development and Evaluation, GRADE) and developed as a change management strategy. A second change management strategy—in collaboration with the European Academy of Allergy and Clinical Immunology ...
Jean Bousquet, Bernardo Sousa‐Pinto, Mohamed H. Shamji, Maria J. Torres, Ludger Klimek, Holger J. Schünemann, Mario Morais‐Almeida, Rafael José Vieira, Alkis Togias, Boleslaw Samolinski, Arunas Valiulis, Siân Williams, Oliver Pfaar, Torsten Zuberbier, Anna Bedbrook, Wienczyslawa Czarlewski, Maryam Ali Al‐Nesf, Rita Amaral, Josep M. Anto, Antonio Bognanni, Luisa Brussino, Alvaro A. Cruz, Violeta Kvedariene, Habib Douagui, Nikolaos G. Papadopoulos, G. Walter Canonica, Ivan Cherrez‐Ojeda, Mark Dykewicz, Bilun Gemicioglu, Mattia Giovannini, Brigita Gradauskiene, Tari Haahtela, Cristina Jacomelli, Tuomas Jartti, Miloš Jeseňák, Piotr Kuna, Désirée E. Larenas‐Linnemann, Amir H. A. Latiff, Bryan Martin, Yousser Mohammad, Kari Nadeau, Elizabete Nunes, Ken Ohta, Martial Ouédraogo, Padukudru A. Mahesh, Isabella Pali‐Schölll, Ana Margarida Pereira, Frederico S. Regateiro, Nicolas Roche, Mikhail Sofiev, Luis Taborda‐Barata, Charlotte Suppli Ulrik, Sanna K. Toppila‐Salmi, Marylin Valentin Rostan, Leticia de las Vecillas, Maria Teresa Ventura, Giovanni Viegi, De Yun Wang, He Zhang, Luo Zhang, Giorgio Ciprandi, Juan Carlos Ivancevich, Nikolai Khaltaev, Olga Lourenço, Lucas Leemann, Marine Savouré, Juan Jose Yepes‐Nuñez, Arzu Yorgancioglu, Baharudin Abdullah, Mona Al‐Ahmad, Julijana Asllani, Karl‐C. Bergmann, Jonathan A. Bernstein, Michael S. Blaiss, Fulvio Braido, Pedro Carreiro‐Martins, Lorenzo Cecchi, Antonio F. M. Giuliano, George Christoff, Ieva Cirule, Jaime Correia‐de‐Sousa, Elisio M. Costa, Biljana Cvetkovski, Stefano Del Giacco, Philippe Devillier, Dejan Dokic, Maia Gotua, Maria Antonieta Guzman, Elham Hossny, Tomohisa Iinuma, Carla Irani, Zhanat Ispayeva, Kaja Julge, Igor Kaidashev, Kazi S. Bennoor, Helga Kraxner, Inger Kull, Marek Kulus, Maciej Kupczyk, Andriy Kurchenko, Xin Luo, Stefania La Grutta, Lan Le Thi Tuyet, Michael Makris, Branislava Milenkovic, Neven Miculinic, Sang Min Lee, Stephen Montefort, André Moreira, Joaquim Mullol, Rachel Nadif, Alla Nakonechna, Hugo E. Neffen, Stefania Nicola, Marek Niedoszytko, Dieudonné Nyembue, Robyn E. O’Hehir, Ismail Ogulur, Yoshitaka Okamoto, Markus Ollert, Heidi Olze, Oscar Palomares, Petr Panzner, Hae‐Sim Park, Vincenzo Patella, Ruby Pawankar, Constantinos Pitsios, Todor A. Popov, Francesca Puggioni, Santiago Quirce, Agné Ramonaité, Marysia Recto, Maria Susana Repka‐Ramirez, Karla Robles‐Velasco, Menachem Rottem, Marianella Salapatas, Joaquin Sastre, Nicola Scichilone, Juan‐Carlos Sisul, Dirceu Solé, Manuel Soto‐Martinez, Milan Sova, Katarina Stevanovic, Pongsakorn Tantilipikorn, Ana Todo‐Bom, Vladyslav Tsaryk, Ioanna Tsiligianni, Marilyn Urrutia‐Pereira, Erkka Valovirta, Tuula Vasankari, Dana Wallace, Margitta Worm, Osman M. Yusuf, Fares Zaitoun, Mihaela Zidarn, on behalf of ARIA study group   +155 more
wiley   +1 more source

Dupilumab Combined With House Dust Mite Allergen Immunotherapy for Atopic Dermatitis: A Systematic Review and Meta‐Analysis

Clinical and Translational Allergy, Volume 16, Issue 8, August 2026.
ABSTRACT Background Dupilumab is effective for moderate‐to‐severe atopic dermatitis (AD), but sustained disease control after treatment discontinuation remains challenging. House dust mite allergen immunotherapy (HDM‐AIT) may provide disease‐modifying effects in sensitized patients, but the added value of combining HDM‐AIT with dupilumab remains ...
Jiale Lian, Ling Ren, Jing Liang, Shuping Guo   +3 more
wiley   +1 more source